This process results in miR-21 gene expression/production, a reduction of PDCD4 (a tumor suppressor protein), and an upregulation of survival proteins as well as an enhancement of cisplatin-resistance in HNSCC cells [42]. The gene discussed is PDCD4; the disease is head and neck squamous cell carcinoma.